v3.25.2
Segment Information - Reconciliation of Adjusted EBITDA to Income Before Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Segment Reporting Information [Line Items]        
Other revenue $ 1,339,579 $ 1,281,748 $ 2,692,751 $ 2,602,959
Other costs of services (1,184,129) (1,121,943) (2,356,740) (2,242,654)
Depreciation and amortization (34,848) (36,069) (69,656) (71,653)
Equity in earnings of unconsolidated subsidiaries 13,618 9,991 26,130 20,412
Interest expense (29,978) (27,994) (59,050) (68,675)
Income from continuing operations before income taxes 70,171 55,853 166,356 144,062
Operating Segments | Critical Illness Recovery Hospital        
Segment Reporting Information [Line Items]        
Adjusted EBITDA 56,283 71,833 142,932 187,773
Other revenue 601,139 604,921 1,238,169 1,260,801
Operating Segments | Rehabilitation Hospital        
Segment Reporting Information [Line Items]        
Adjusted EBITDA 71,047 61,954 141,471 123,354
Other revenue 313,775 267,831 621,163 533,531
Operating Segments | Outpatient Rehabilitation        
Segment Reporting Information [Line Items]        
Adjusted EBITDA 30,513 28,769 54,786 53,697
Other revenue 327,584 315,496 634,926 618,654
Other        
Segment Reporting Information [Line Items]        
Other revenue 97,081 93,500 198,493 189,973
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment        
Segment Reporting Information [Line Items]        
Other costs of services (97,081) (93,500) (198,493) (189,973)
Other general and administrative expenses (32,504) (37,827) (62,405) (74,320)
Other other operating income 72 0 72 0
Depreciation and amortization (34,848) (36,069) (69,656) (71,653)
Stock compensation expense (4,032) (14,247) (7,924) (25,691)
Concentra separation transaction costs 0 (557) 0 (835)
Equity in earnings of unconsolidated subsidiaries 13,618 9,991 26,130 20,412
Interest expense $ (29,978) $ (27,994) $ (59,050) $ (68,675)